Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke

Conclusion: Hemorrhagic stroke was not occurred in our observation of EPA prescribed patients. The clinical features of recurrent stroke patients were the existing complications of dyslipidemia and renal dysfunction.
Source: Clinical and Translational Medicine - Category: Internal Medicine Authors: Source Type: research